Free Trial

Lexeo Therapeutics (LXEO) Stock Forecast & Price Target

Lexeo Therapeutics logo
$5.35 +0.04 (+0.75%)
Closing price 09/23/2025 04:00 PM Eastern
Extended Trading
$5.45 +0.10 (+1.85%)
As of 09/23/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lexeo Therapeutics - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
0
Buy
6

Based on 6 Wall Street analysts who have issued ratings for Lexeo Therapeutics in the last 12 months, the stock has a consensus rating of "Buy." Out of the 6 analysts, 6 have given a buy rating for LXEO.

Consensus Price Target

$15.33
186.60% Upside
According to the 6 analysts' twelve-month price targets for Lexeo Therapeutics, the average price target is $15.33. The highest price target for LXEO is $20.00, while the lowest price target for LXEO is $9.00. The average price target represents a forecasted upside of 186.60% from the current price of $5.35.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for LXEO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Lexeo Therapeutics and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LXEO Analyst Ratings Over Time

TypeCurrent Forecast
9/24/24 to 9/24/25
1 Month Ago
8/25/24 to 8/25/25
3 Months Ago
6/26/24 to 6/26/25
1 Year Ago
9/25/23 to 9/24/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
8 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$15.33$15.33$16.60$22.14
Forecasted Upside186.60% Upside229.04% Upside297.13% Upside150.48% Upside
Consensus RatingBuyBuyBuyBuy

LXEO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LXEO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Lexeo Therapeutics Stock vs. The Competition

TypeLexeo TherapeuticsMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.78
2.53
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside186.60% Upside2,727.77% Upside11.37% Upside
News Sentiment Rating
Positive News

See Recent LXEO News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/15/2025Chardan Capital
1 of 5 stars
Geulah Livshits
Geulah Livshits
3 of 5 stars
Lower TargetBuy$20.00 ➝ $15.00+217.80%
8/15/2025HC Wainwright
1 of 5 stars
Mitchell S.
Mitchell S.
Not Rated
Lower TargetBuy$15.00 ➝ $9.00+87.89%
7/31/2025Oppenheimer
2 of 5 stars
Leland Gershell
Leland Gershell
4 of 5 stars
Initiated CoverageOutperform$20.00+330.11%
5/30/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$16.00 ➝ $10.00+262.98%
3/25/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOutperform$24.00 ➝ $20.00+415.46%
3/24/2025Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOutperform$19.00 ➝ $18.00+423.25%
6/13/2024Baird R W
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
6/13/2024Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageOutperform$28.00+53.93%
11/28/2023Leerink Partnrs
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
11/28/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageBuy$20.00+81.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 02:50 AM ET.


LXEO Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Lexeo Therapeutics is $15.33, with a high forecast of $20.00 and a low forecast of $9.00.

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lexeo Therapeutics in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LXEO shares.

According to analysts, Lexeo Therapeutics's stock has a predicted upside of 186.60% based on their 12-month stock forecasts.

Lexeo Therapeutics has been rated by research analysts at Chardan Capital, HC Wainwright, and Oppenheimer in the past 90 days.

Analysts like Lexeo Therapeutics more than other "medical" companies. The consensus rating for Lexeo Therapeutics is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how LXEO compares to other companies.


This page (NASDAQ:LXEO) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners